111 related articles for article (PubMed ID: 28714371)
1. High expression of nucleobindin 2 is associated with poor prognosis in gastric cancer.
Altan B; Kaira K; Okada S; Saito T; Yamada E; Bao H; Bao P; Takahashi K; Yokobori T; Tetsunari O; Nishiyama M; Yamada M
Tumour Biol; 2017 Jul; 39(7):1010428317703817. PubMed ID: 28714371
[TBL] [Abstract][Full Text] [Related]
2. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of NUCB2 mRNA expression in prostate cancer.
Zhang H; Qi C; Li L; Luo F; Xu Y
J Exp Clin Cancer Res; 2013 Aug; 32(1):56. PubMed ID: 23958433
[TBL] [Abstract][Full Text] [Related]
4. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
5. Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer.
Tanaka T; Nakamura J; Kitajima Y; Kai K; Miyake S; Hiraki M; Ide T; Koga Y; Noshiro H
Int J Oncol; 2013 Mar; 42(3):894-902. PubMed ID: 23291975
[TBL] [Abstract][Full Text] [Related]
6. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
Qi C; Ma H; Zhang HT; Gao JD; Xu Y
Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
[TBL] [Abstract][Full Text] [Related]
7. VEZT as a novel independent prognostic factor in gastric cancer.
Li YS; Chen YZ; Guo XB; Liu X; Li LP
Cancer Biomark; 2015; 15(4):375-80. PubMed ID: 25792470
[TBL] [Abstract][Full Text] [Related]
8. High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer.
Zhang H; Qi C; Wang A; Li L; Xu Y
Tumour Biol; 2014 Mar; 35(3):2025-8. PubMed ID: 24092574
[TBL] [Abstract][Full Text] [Related]
9. MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma.
Yao Z; Yuan T; Wang H; Yao S; Zhao Y; Liu Y; Jin S; Chu J; Xu Y; Zhou W; Yang S; Liu Y
Tumour Biol; 2017 Jun; 39(6):1010428317700411. PubMed ID: 28621235
[TBL] [Abstract][Full Text] [Related]
10. Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.
Wang JH; Tang HS; Li XS; Zhang XL; Yang XZ; Zeng LS; Ruan Q; Huang YH; Liu GJ; Wang J; Cui SZ
Oncotarget; 2017 May; 8(19):31682-31691. PubMed ID: 28404958
[TBL] [Abstract][Full Text] [Related]
11. Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.
Liu K; Li G; Fan C; Diao Y; Wu B; Li J
J Int Med Res; 2012; 40(2):467-74. PubMed ID: 22613407
[TBL] [Abstract][Full Text] [Related]
12. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
13. TKTL1 and p63 are biomarkers for the poor prognosis of gastric cancer patients.
Song Y; Liu D; He G
Cancer Biomark; 2015; 15(5):591-7. PubMed ID: 26406948
[TBL] [Abstract][Full Text] [Related]
14. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
[TBL] [Abstract][Full Text] [Related]
15. High expression of Rac1 is correlated with partial reversed cell polarity and poor prognosis in invasive ductal carcinoma of the breast.
Liu B; Xiong J; Liu G; Wu J; Wen L; Zhang Q; Zhang C
Tumour Biol; 2017 Jul; 39(7):1010428317710908. PubMed ID: 28671041
[TBL] [Abstract][Full Text] [Related]
16. Upregulated Vav2 in gastric cancer tissues promotes tumor invasion and metastasis.
Tan BB; Li Y; Fan LQ; Zhao Q; Liu QW; Liu Y; Wang D; Jia N
Tumour Biol; 2017 May; 39(5):1010428317698392. PubMed ID: 28459214
[TBL] [Abstract][Full Text] [Related]
17. Expression of early growth response-1 in human gastric cancer and its relationship with tumor cell behaviors and prognosis.
Myung E; Park YL; Kim N; Chung CY; Park HB; Park HC; Myung DS; Kim JS; Cho SB; Lee WS; Joo YE
Pathol Res Pract; 2013 Nov; 209(11):692-9. PubMed ID: 24011795
[TBL] [Abstract][Full Text] [Related]
18. Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.
Gao H; Lan X; Li S; Xue Y
Tumour Biol; 2017 May; 39(5):1010428317698368. PubMed ID: 28459196
[TBL] [Abstract][Full Text] [Related]
19. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
20. Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer.
Zhang H; Qi C; Wang A; Yao B; Li L; Wang Y; Xu Y
J Exp Clin Cancer Res; 2013 Oct; 32(1):77. PubMed ID: 24422979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
